Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 194 of 641 · 7,691 filings

  • Atlantic Union Bankshares (AUB) FY2025 10-K risk factors
    52 risks1 new15 dropped12 reworded

    Merger-related integration and stock dilution risks from Sandy Spring were dropped after completion. New tax position review risks were added. Interest rate exposure was updated to reflect 2024 and 2025 FOMC rate cuts totaling 175 bps. Management disclosed an ongoing Chief Financial Officer transition.

    Filed Feb 26, 2026
  • Aurinia Pharmaceuticals (AUPH) FY2025 10-K risk factors
    30 risks2 new5 dropped9 reworded

    U.S. pharmaceutical trade-policy investigation creates new exposure for Canadian operations importing Swiss-manufactured products.

    Filed Feb 26, 2026
  • AvePoint (AVPT) FY2025 10-K risk factors
    101 risks

    AvePoint's disclosures focus on enterprise cloud software, data protection, and artificial intelligence integration.

    Filed Feb 26, 2026
  • Anteris Technologies Global (AVR) FY2025 10-K risk factors
    67 risks

    Anteris is pre-commercial, with $94.2 million 2025 losses and $77.8 million negative operating cash flow.

    Filed Feb 26, 2026
  • Atlanta Braves Holdings (BATRA) FY2025 10-K risk factors
    34 risks3 new7 dropped11 reworded

    John C. Malone controls 50.0% of voting power, influencing corporate actions and potential change of control transactions.

    Filed Feb 26, 2026
  • Barrett Business Services (BBSI) FY2025 10-K risk factors
    46 risks3 new10 reworded

    BBSI added risks concerning tariffs, trade policies, and state-level climate regulations affecting clients.

    Filed Feb 26, 2026
  • Brinks (BCO) FY2025 10-K risk factors
    25 risks6 reworded

    The new share-repurchase authorization permits up to $750 million through December 31, 2027, replacing the 2023 program.

    Filed Feb 26, 2026
  • Biocryst Pharmaceuticals (BCRX) FY2025 10-K risk factors
    63 risks16 new8 dropped17 reworded

    Merger integration risks regarding Astria and its product candidate navenibart dominate the newly added disclosures. New disclosures address the path to sustained profitability after achieving first annual net income in 2025. Risks related to generic and biosimilar competition are expanded.

    Filed Feb 26, 2026
  • Biodesix (BDSX) FY2025 10-K risk factors
    108 risks9 new10 dropped17 reworded

    Biodesix added numerous risks regarding FDA regulation of laboratory-developed tests, artificial intelligence adoption, patent protection, and maintaining Nasdaq minimum bid price compliance following a reverse stock split.

    Filed Feb 26, 2026
  • Bright Horizons Family Solutions (BFAM) FY2025 10-K risk factors
    28 risks2 new1 dropped7 reworded

    AI adoption is newly identified as a competitive and service-delivery risk.

    Filed Feb 26, 2026
  • Business First Bancshares (BFST) FY2025 10-K risk factors
    53 risks1 dropped4 reworded

    The bank grew its large loan exposure, with average loan size rising to $542,000 and top ten relationships averaging $65.0 million. Cyber-crime threats and FDIC insurance assessment contexts were updated to reflect recent financial industry events.

    Filed Feb 26, 2026
  • BankUnited (BKU) FY2025 10-K risk factors
    38 risks2 new4 dropped6 reworded

    Climate change disclosures now specifically address rising Florida coastal property insurance costs and physical weather risks. Artificial intelligence adoption and evolving digital asset regulations introduced as a strategic risk. Talent recruitment and hybrid work dynamics formalized into a standalone human capital risk.

    Filed Feb 26, 2026

Companies covered

4,011 companies

371 more under A